Ideal for use in power hungry applications such as industrial and medical imaging and inspection, high resolution printing and emerging technologies where precision and sensitivity are vital, the laser modules are a complete laser solution for OEMs.
The extra output power offered by these laser modules also provides higher energy density and greater accuracy and sensitivity for biomedical and biochemical analysis applications such as flow cytometry and laser-induced fluorescence sensing.
Designed to be extremely stable and reliable, the 405nm Photon laser modules produce an elliptical output beam of 3.5 x 2mm with the added advantage of TTL modulation input which will accept signals from DC up to 1 kHz maximum and can be used to enable, inhibit or modulate the laser.
The glass AR coated aspherical lens may be adjusted to produce either a collimated beam or focused spot. The standard lens may be replaced by other optical systems such as line generators.
Operating voltage is from 8V to 10V D. Beam divergence is typically <0.6 x 0.3mrad. Operating temperature range is -10 to +50 degrees Centigrade.
The modules are cylindrical with an optional 25mm mounting flange and consist of an aluminium housing, laser diode, drive circuit and collimating lens. They measure a compact 12 mm diameter x 43mm length. Electrical connections are made via external flying leads.
ABOUT Photonic Products Ltd
Photonic Products is a UK based, ISO9001:2000 certified manufacturer of custom designed laser diode modules and assemblies and an authorised distributor of high performance, premium quality industrial laser diodes and LEDs manufactured by Sanyo, Opnext (formerly Hitachi) and Sony, and precision optical lenses from Panasonic to OEMs in the industrial, medical, scientific and defence markets.
Photonic Products was established in 1995 and has operations in the United Kingdom, the United States and Germany.
The company has twice been honoured with a Queen's Award for Enterprise: International Trade.
It is a StockerYale (NASDAQ: STKR) company.
This news release is issued in accordance with clause 1.2j of the British Codes of Advertising and Sales Promotion, and therefore cannot be subject to a transaction of any kind.
NOTICE TO INVESTORS:
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. All statements other than statements of historical fact, including without limitation, those with respect to StockerYale's goals, plans and strategies set forth herein are forward-looking statements. The following important factors and uncertainties, among others, could cause actual results to differ materially from those described in these forward-looking statements: uncertainty that cash balances may not be sufficient to allow StockerYale to meet all of its business goals; uncertainty that StockerYale's new products will gain market acceptance; the risk that delays and unanticipated expenses in developing new products could delay the commercial release of those products and affect revenue estimates; the risk that one of our competitors could develop and bring to market a technology that is superior to those products that we are currently developing; and StockerYale's ability to capitalize on its significant research and development efforts by successfully marketing those products that the Company develops. Forward-looking statements represent management's current expectations and are inherently uncertain. You should also refer to the discussion under "Factors Affecting Operating Results" in StockerYale's annual report on Form 10-KSB and most recent quarterly report on Form 10-QSB for additional matters to be considered in this regard. Thus, actual results may differ materially. All Company, brand, and product names are trademarks or registered trademarks of their respective holders. StockerYale undertakes no duty to update any of these forward-looking statements.